ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,930.00
      -0.76%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.17
      -0.06%
      Bitcoin
      63,903.91
      -0.59%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Akebia Therapeutics Inc (AKBA)

      7. Akebia Therapeutics Inc (AKBA) News

      AKBA Akebia Therapeutics Inc

      1.36
      0.00 (0.00%)
      Pre Market
      Last Updated: 05:45:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Akebia Therapeutics Inc AKBA NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 1.36 05:45:00
      Open Price Low Price High Price Close Price Prev Close
      1.36
      more quote information »

      Recent News

      Date Time Source Heading
      4/02/202416:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
      3/27/202420:26PRNUSAkebia Receives FDA Approval of Vafseo® (vadadustat) Tablets..
      3/14/202416:15PRNUSAkebia Therapeutics Reports Fourth Quarter and Full Year..
      3/11/202417:05PRNUSAkebia Therapeutics to Report Fourth Quarter and Full Year..
      3/01/202417:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/01/202417:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/01/202417:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/01/202417:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/01/202416:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
      2/29/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202418:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202416:32EDGAR2Form 144 - Report of proposed sale of securities
      2/29/202416:28EDGAR2Form 144 - Report of proposed sale of securities
      2/29/202416:27EDGAR2Form 144 - Report of proposed sale of securities
      2/27/202418:19EDGAR2Form 144 - Report of proposed sale of securities
      2/27/202418:14EDGAR2Form 144 - Report of proposed sale of securities
      2/27/202418:11EDGAR2Form 144 - Report of proposed sale of securities
      2/13/202408:00EDGAR2Form 8-K - Current report
      2/02/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
      2/01/202416:52EDGAR2Form 144 - Report of proposed sale of securities
      1/30/202416:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
      1/30/202408:05EDGAR2Form 8-K - Current report
      1/30/202408:00PRNUSAkebia Secures $55 Million Term Loan Financing
      1/18/202417:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/09/202408:30PRNUSAkebia Therapeutics Announces Appointment of Nicholas Grund..
      1/08/202416:08EDGAR2Form 8-K - Current report
      1/08/202408:02EDGAR2Form 8-K - Current report
      1/02/202416:30PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
      12/20/202308:00PRNUSAkebia Therapeutics to Present at the 42nd Annual J.P...
      12/18/202316:07EDGAR2Form 8-K - Current report
      12/01/202316:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
      11/21/202317:07EDGAR2Form 8-K - Current report
      11/20/202308:00PRNUSAkebia Therapeutics to Present at Piper Sandler Healthcare..
      11/08/202307:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/08/202307:33EDGAR2Form 8-K - Current report
      11/08/202307:30PRNUSAkebia Therapeutics Reports Third Quarter 2023 Financial..
      11/02/202316:34EDGAR2Form 8-K - Current report
      11/02/202316:30PRNUSAkebia Therapeutics Announces Favorable Payment Term..
      11/01/202316:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
      10/31/202308:00PRNUSAkebia Therapeutics to Report Third Quarter 2023 Financial..
      10/25/202316:06EDGAR2Form 8-K - Current report

      Your Recent History

      NASDAQ
      AKBA
      Akebia Therapeutics
      Delayed Upgrade Clock